Shandong hailir Chemical Co., Ltd. is located in the green chemical park of Weifang Binhai Economic and Technological Development Zone. It was established on December 17, 2007 with a registered capital of 51.66 million yuan, accounting for more than 300 mu of the ground. The company is mainly engaged in the production and sales of new nicotine insecticides and fungicides. The market share of the main products is the first in the country. Our company is a national high-tech enterprise, an invisible champion, a single champion, and a specialized and special new enterprise.
At present, the company's leading products are mainly oriented to the international and domestic markets, of which the international market accounts for more than 1 / 3 of the total sales. In 2019, the sales revenue was 880 million yuan and the tax payment was 57.75 million yuan; In 2020, the sales income was more than 1 billion yuan, and the tax payment was 66.7 million yuan. In 2021, the main business income of Shandong hailir Chemical Co., Ltd. was 1.37 billion yuan, the output value was 1.56 billion yuan, and the tax payment was 64.5 million yuan; In the first quarter of 2022, the output value was 380 million yuan and the tax payment was 8.5 million yuan. It has been ranked in the forefront of tax payment in Binhai Development Zone for many consecutive years.
Relying on Weifang enterprise technology center and Weifang Engineering Laboratory, the company undertakes one national 863 Program project. Participated in the formulation of 2 national / industrial standards and the transformation of 17 scientific and technological achievements. All intellectual property rights of the company are applied to product production. The production process of imidacloprid technical drug produced by the company has reached the international leading level, raising the yield from 85% of the original process to 92%, and reducing the wastewater from 6 tons to 0.8 tons, far exceeding the highest level in the industry. It has a strong driving and leading role in the development of the industry.
In 2022, the company invested 300 million yuan to use the company's original land to newly build the annual production of insecticide technical drugs project. The main products are thiamethoxam and thiamethoxam. It is currently the largest production line in China, and its technical level is internationally leading. It is currently under construction. It has reached an intention order agreement with Syngenta. After it is put into production, the annual operating income will increase by 520 million yuan and the tax will increase by 30 million yuan.
In 2022, the company used the company's original land to invest 300 million yuan in the new annual production of new fungicides, herbicide technical drugs and technical drug intermediates construction project. The main product prethioxazole is the first registered product in China, and its technical level is in the international lead. It has broken through the technical barriers of multinational companies. At present, it has reached an intended supply agreement with multinational companies. After it is put into production, the annual operating income will increase by 1 billion yuan and the tax will increase by 60 million yuan.
After the two new projects are all put into operation, it is planned to create 200 new jobs. It is expected that the sales income will be more than 2 billion yuan and the tax payment will exceed 100 million yuan in 2022.
At the same time, adhering to the enterprise concept of "people-oriented", the company has successfully gathered a group of elites in the agricultural and chemical industry. In terms of personnel structure, the proportion of senior, intermediate and junior technical personnel is reasonable according to the principle of complementary advantages and professionals; The regions of different ages complement each other, mainly middle-aged and young scientific and technological personnel with the strongest physical strength, intelligence and creativity. The company has more than 750 employees, including 102 scientific and technological R & D personnel. Among the R & D personnel, there are 2 doctors and 9 masters.
In order to realize the healthy development of the construction of excellent talent echelons for recruiting, retaining and cultivating talents, our company plans to purchase expert apartments, single apartments and other supporting service outlets for the company's employees, especially young excellent talents, in Binhai Development Zone in 2022, so that talents can stay, live well and live well.
